Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis

Journal of the American Academy of Dermatology

Volumn 41, Issue 5 II, 1999, Pages 880-883

  Haley, H R ^a   Davis, D A ^a   Sams, W M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; GENE REARRANGEMENT; HUMAN; MALE; PRIORITY JOURNAL; PUVA; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0032722756     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70351-8     Document Type: Article

References (23)

1. MA Weinstock JW. Horm Mycosis fungoides in the United States JAMA 260 1988 42 46
2. LM Weiss E Hu GS Wood C Moulds ML Cleary R Warnke Clonal rearrangements of cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy N Engl J Med 313 1985 539 544
3. JR Toro HL Stoll PC Stomper AR. Oseroff Prognostic factors and evaluation of mycosis fungoides and Sezary syndrome J Am Acad Dermatol 37 1997 58 67
4. YH Kim RA Jensen GL Watanabe A Varghese RT. Hoppe Clinical stage IA (limited patch and plaque) mycosis fungoides Arch Dermatol 132 1996 1309 1313
5. JS Weiselthier HK. Koh Sezary syndrome: diagnosis, prognosis and critical review of treatment options J Am Acad Dermatol 22 1990 381 401
6. AH Rook SL Gottlieb JT Wolfe BR Vowels SS Sood Z Niu Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis Clin Exp Immunol 107 Suppl 1 1997 16 20
7. RB Heberman JR Ortaldo JY Djeu HT Holden J Jett NP Lang Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages Ann NY Acad Sci 350 1980 63 71
8. BR Vowels M Cassin EC Vonderheid AH. Rook Aberrant cytokine production Sezary syndrome patients: cytokine secretion pattern resembles murine TH2 cells J Invest Dermatol 99 1992 90 94
9. AH Rook MB Prystowsky M Cassin M Boufal SR. Lessin Combined therapy for Sezary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy Arch Dermatol 127 1991 1535 1540
10. BR Vowels SR Lessin M Cassin C Jaworsky B Benoit JT Wolfe Th2 cytokine mRNA expression in skin in cutaneous T cell lymphoma J Invest Dermatol 103 1994 669 673
11. ER Steihm LH Kronenberg HM Rosenblatt Y Bryson TC. Merigan Interferon: immunobiology and clinical significance Ann Int Med 96 1982 80 93
12. PA Bunn DC Ihde KA. Foon The role of recombinant interferon alpha-2a in the therapy of cutaneous T-cell lymphoma Cancer 57 1986 1689 1695
13. EC Vonderheid RD Bigler AS Greenberg SJ Neukum B. Micaily Extracorporeal photopheresis and recombinant interferon alpha 2b in Sezary syndrome Am J Clin Oncol 17 1994 255 263
14. JR Quesada M Talpaz A Rios R Kurzock JU. Gutterman Clinical toxicity of interferons in cancer patients: a review J Clin Oncol 4 1986 234 243
15. SL Gottlieb JT Wolfe FE Fox BJ DeNardo WH Macey PG Bromley Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alpha: a 10-year experience at a single institution J Am Acad Dermatol 35 1996 946 957
16. PW Heald MI Perez I Christensen N Dobbs G McKiernan R. Edelson Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven hospital experience Yale J Biol Med 62 1989 629 638
17. RL. Edelson Photopheresis: a clinically relevant immunobiologic response modifier Ann NY Acad Med 636 1991 154 164
18. BR Vowels M Cassin MH Boufal LJ Walsh AH. Rook Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis J Invest Dermatol 98 1992 686 692
19. DI Marks SP Rockman MA Oziemski RM. Fox Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma J Clin Invest 86 1990 2080 2085
20. JJ Herrmann TM Kuzel ST Rosen HH. Roenigk Proceedings of the second international symposium on cutaneous T-cell lymphoma J Am Acad Dermatol 31 1994 819 822
21. JT Wolfe SR Lessin AH Singh AH. Rook Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection Artif Organs 18 1994 888 897
22. P Heald A Rook M Perez B Wintroub R Knobler B Jegasothy Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy J Am Acad Dermatol 27 1992 427 433
23. EA Sausville JL Eddy RW Makuch AB Fischmann GP Schechter M Matthews Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome Ann Int Med 109 1988 372 382